Use of Rapid Antigen Testing for SARS-CoV-2 in Remote Communities — Yukon-Kuskokwim Delta Region, Alaska, September 15, 2020-March 1, 2021
Morbidity and Mortality Weekly Report, ISSN: 1545-861X, Vol: 70, Issue: 33, Page: 1120-1123
2021
- 11Citations
- 46Captures
- 2Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes10
- 10
- Policy Citations1
- Policy Citation1
- Captures46
- Readers46
- 46
- Mentions2
- News Mentions2
- News2
Most Recent News
The war against Covid is over – if we want it to be
The rhetoric of warfare dominated the airways early in the pandemic. When Xi Jinping initially toured Wuhan, he declared that China would win a “people’s
Article Description
What is already known about this topic? Until the widespread availability of rapid point-of-care COVID-19 testing, one of the primary challenges in rural Alaska was slow turnaround times for SARS-CoV-2 laboratory-based nucleic acid amplification test results. What is added by this report? Introduction of rapid, point-of-care antigen testing in Alaska's remote Yukon-Kuskokwim Delta region was followed by a more than threefold reduction in daily SARS-CoV-2 case rates during approximately 1 month before the introduction of COVID-19 vaccination. What are the implications for public health practice? Rapid point-of-care antigen testing shortens the turn-around time and might be a valuable tool in reducing transmission of SARS-CoV-2 in rural communities by facilitating rapid isolation and quarantine.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85113840504&origin=inward; http://dx.doi.org/10.15585/mmwr.mm7033a3; http://www.ncbi.nlm.nih.gov/pubmed/34411078; http://www.cdc.gov/mmwr/volumes/70/wr/mm7033a3.htm?s_cid=mm7033a3_w; https://dx.doi.org/10.15585/mmwr.mm7033a3; https://www.cdc.gov/mmwr/volumes/70/wr/mm7033a3.htm?s_cid=mm7033a3_w
Centers for Disease Control MMWR Office
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know